97 related articles for article (PubMed ID: 9117086)
1. Degradation of bradykinin by bovine tracheal epithelium and isolated epithelial cells.
Dendorfer A; Vordermark D; Dominiak P
Br J Pharmacol; 1997 Jan; 120(1):121-9. PubMed ID: 9117086
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of kininogen and degradation of bradykinin by PC12 cells.
Dendorfer A; Wellhöner P; Braun A; Roscher AA; Dominiak P
Br J Pharmacol; 1997 Dec; 122(8):1585-92. PubMed ID: 9422802
[TBL] [Abstract][Full Text] [Related]
3. Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart.
Dendorfer A; Wolfrum S; Wellhöner P; Korsman K; Dominiak P
Br J Pharmacol; 1997 Nov; 122(6):1179-87. PubMed ID: 9401784
[TBL] [Abstract][Full Text] [Related]
4. Kinin metabolism in the perfused ventilated rat lung. I: Bradykinin metabolism in a system modeling the normal, uninjured lung.
Baker CR; Little AD; Little GH; Canizaro PC; Behal FJ
Circ Shock; 1991 Jan; 33(1):37-47. PubMed ID: 2009602
[TBL] [Abstract][Full Text] [Related]
5. [Effect of bradykinin on airway epithelial ion transport and its modulation by endogenous peptidases].
Isono K; Tamaoki J; Chiyotani A; Konno K
Kokyu To Junkan; 1993 Jun; 41(6):581-5. PubMed ID: 8337517
[TBL] [Abstract][Full Text] [Related]
6. Uncoupling of bradykinin-induced phosphoinositide hydrolysis and Ca2+ mobilization by phorbol ester in canine cultured tracheal epithelial cells.
Yang CM; Luo SF; Wu WB; Pan SL; Tsai YJ; Chiu CT; Wang CC
Br J Pharmacol; 1998 Oct; 125(4):627-36. PubMed ID: 9831895
[TBL] [Abstract][Full Text] [Related]
7. Kinin B2 receptor-mediated bradykinin internalization and metalloendopeptidase EP24.15-dependent intracellular bradykinin degradation.
Sandén C; Enquist J; Bengtson SH; Herwald H; Leeb-Lundberg LM
J Pharmacol Exp Ther; 2008 Jul; 326(1):24-32. PubMed ID: 18430865
[TBL] [Abstract][Full Text] [Related]
8. Effects of bradykinin on signal transduction, cell proliferation, and cytokine, prostaglandin E2 and collagenase-1 release from human corneal epithelial cells.
Wiernas TK; Davis TL; Griffin BW; Sharif NA
Br J Pharmacol; 1998 Mar; 123(6):1127-37. PubMed ID: 9559896
[TBL] [Abstract][Full Text] [Related]
9. Contributions of various rat plasma peptidases to kinin hydrolysis.
Ishida H; Scicli AG; Carretero OA
J Pharmacol Exp Ther; 1989 Dec; 251(3):817-20. PubMed ID: 2557417
[TBL] [Abstract][Full Text] [Related]
10. The expression of functionally-coupled B2-bradykinin receptors in human corneal epithelial cells and their pharmacological characterization with agonists and antagonists.
Wiernas TK; Griffin BW; Sharif NA
Br J Pharmacol; 1997 Jun; 121(4):649-56. PubMed ID: 9208130
[TBL] [Abstract][Full Text] [Related]
11. Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC.
Matsumura Y; Maeda H; Kato H
Agents Actions; 1990 Mar; 29(3-4):172-80. PubMed ID: 2160186
[TBL] [Abstract][Full Text] [Related]
12. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic digestion of bradykinin by rat Sertoli cell cultures.
Monsees TK; Miska W; Schill WB
J Androl; 1996; 17(4):375-81. PubMed ID: 8889700
[TBL] [Abstract][Full Text] [Related]
14. Structural requirements for B2-agonists with improved degradation stability.
Dendorfer A; Wagemann M; Reissmann S; Dominiak P
Immunopharmacology; 1999 Dec; 45(1-3):199-205. PubMed ID: 10615012
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of both aminopeptidase P and angiotensin-converting enzyme prevents bradykinin degradation in the rat coronary circulation.
Erşahin C; Simmons WH
J Cardiovasc Pharmacol; 1997 Jul; 30(1):96-101. PubMed ID: 9268227
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin promotes ischemic norepinephrine release in guinea pig and human hearts.
Hatta E; Maruyama R; Marshall SJ; Imamura M; Levi R
J Pharmacol Exp Ther; 1999 Mar; 288(3):919-27. PubMed ID: 10027827
[TBL] [Abstract][Full Text] [Related]
17. Neutral endopeptidase up-regulation in isolated human umbilical artery: involvement in desensitization of bradykinin-induced vasoconstrictor effects.
Pelorosso FG; Halperin AV; Palma AM; Nowak W; Errasti AE; Rothlin RP
J Pharmacol Exp Ther; 2007 Feb; 320(2):713-20. PubMed ID: 17085545
[TBL] [Abstract][Full Text] [Related]
18. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
Miyamoto A; Murata S; Nishio A
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):365-70. PubMed ID: 12012022
[TBL] [Abstract][Full Text] [Related]
19. Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung.
Prechel MM; Orawski AT; Maggiora LL; Simmons WH
J Pharmacol Exp Ther; 1995 Dec; 275(3):1136-42. PubMed ID: 8531074
[TBL] [Abstract][Full Text] [Related]
20. Carboxypeptidase B and other kininases of the rat coronary and mesenteric arterial bed perfusates.
Oliveira EB; Souza LL; Sivieri DO; Bispo-da-Silva LB; Pereira HJ; Costa-Neto CM; Sousa MV; Salgado MC
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3550-7. PubMed ID: 17906107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
